Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett loves a good metaphor. One of his most potent Read More
Citigroup Maintains Alkami Technology (ALKT) Buy Recommendation
Fintel reports that on May 5, 2023, Citigroup maintained coverage of Alkami Technology (NASDAQ:ALKT) with a Buy recommendation.Read More
Pason Systems said on May 4, 2023 that its board of directors declared a regular quarterly dividend of $0.12 per share ($0.48 annualized). Previously, Read More
Pason Systems said on May 4, 2023 that its board of directors declared a regular quarterly dividend of $0.12 per share ($0.48 annualized). Previously, Read More
Popular Capital Trust II – 6.125% PRF CONVERT 01 said on May 4, 2023 that its board of directors declared a regular monthly dividend of $0.13 Read More
Popular Capital Trust II – 6.125% PRF CONVERT 01 said on May 4, 2023 that its board of directors declared a regular monthly dividend of $0.13 Read More
Klabin S.A. – ADR said on May 4, 2023 that its board of directors declared a regular quarterly dividend of $0.14 per share ($0.57 Read More
Klabin S.A. – ADR said on May 4, 2023 that its board of directors declared a regular quarterly dividend of $0.14 per share ($0.57 Read More
Prologis Inc – 8.54% PRF PERPETUAL USD – Ser Q said on May 4, 2023 that its board of directors declared a regular quarterly dividend Read More
Prologis Inc – 8.54% PRF PERPETUAL USD – Ser Q said on May 4, 2023 that its board of directors declared a regular quarterly dividend Read More
Warren Buffett said on Saturday he could not imagine Washington allowing the U.S. to default on its debt by Read More
Charlie Munger expects ‘old fashioned intelligence works pretty well’ over AI Billionaire investor Charlie Munger expressed skepticism in response to Read More
Cantor Fitzgerald Maintains 89bio (ETNB) Overweight Recommendation
Fintel reports that on May 5, 2023, Cantor Fitzgerald maintained coverage of 89bio (NASDAQ:ETNB) with a Overweight recommendation.Read More
Morgan Stanley Maintains Blueprint Medicines (BPMC) Equal-Weight
Fintel reports that on May 5, 2023, Morgan Stanley maintained coverage of Blueprint Medicines (NASDAQ:BPMC) with a Equal-Weight recommendation.Read More
Brookfield Property Partners L.P. – 5.75% PRF PERPETUAL USD 25 – Cls A Ser 3 said on May 4, 2023 that its board of directors declared Read More